Profil
Arvind K.
Sood is Chief Strategy & Corporate Affairs Officer at Coherus Oncology, Inc. since 2025.
Former roles include Executive Vice President & President-US Operations at Innate Pharma SA from 2024 to 2025, Vice President-Investor Relations at Amgen, Inc., and SVP-Investor Relations & Financial Communications at Aventis SA. Education includes an MBA from Central Michigan University and an undergraduate degree from Western Michigan University.
Postes actifs de Arvind Sood
| Sociétés | Poste | Début |
|---|---|---|
| COHERUS ONCOLOGY, INC. | Public Communications Contact | 06/11/2025 |
Anciens postes connus de Arvind Sood
| Sociétés | Poste | Fin |
|---|---|---|
| INNATE PHARMA | Corporate Officer/Principal | 03/02/2025 |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and vaccines for preventative medicine | Investor Relations Contact | - |
| AMGEN INC. | Investor Relations Contact | - |
Formation de Arvind Sood
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and vaccines for preventative medicine | Health Technology |
Central Michigan University
Central Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Michigan University
Western Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
















